Purchase Order N0017314P3367
- Not listed
- The Office of Naval Research (ONR) awarded a $3,830.85 firm fixed price purchase order to Genscript USA Inc. on June 17, 2016, for protein services with an ultimate completion date of July 21, 2016. The contract, which was not set aside for small businesses, will be performed at the contractor's facility in Piscataway, New Jersey. Genscript USA Inc., a biotechnology company specializing in advanced molecular biology services, was selected to provide these protein-related services in support of...
- The Office of Naval Research awarded a firm fixed-price purchase order valued at $3,477.08 to Genscript USA Inc. for DNA sequencing services. The contract, which was not set aside for small businesses, was awarded on August 8, 2014, with an ultimate completion date of August 29, 2014. The work was performed at Genscript's facility in Piscataway, New Jersey, where the company maintains its headquarters and core operations in advanced molecular biology services. Genscript USA Inc. is a...
- <p>The Office of Naval Research issued a purchase order to Genscript USA Inc. valued at $4,444.42 on April 6, 2017, for peptide synthesis services. Work is performed in Piscataway, New Jersey, with an ultimate completion date of May 31, 2017. The order is firm fixed price with no small business set-aside.</p>
- The U.S. government awarded a $3,194.98 firm fixed-price purchase order to Genscript USA Inc. on May 5, 2015, for custom gene synthesis services. The contract, with an ultimate completion date of September 30, 2015, was funded by a civilian agency within the Midwest Area and performed at the contractor's facility in Piscataway, New Jersey. No set-aside designation was applied to this award. Genscript USA Inc., a biotechnology company specializing in advanced molecular biology services, has...
- The U.S. government awarded a $3,681.17 firm fixed-price purchase order to Genscript USA Inc. for protein synthesis services on April 8, 2019, with a completion date of May 31, 2019. The contract was issued by a civilian federal agency within the Pacific West Area and will be performed at Genscript's headquarters in Piscataway, New Jersey. No set-aside designation was applied to this award, making it available to all qualified vendors in full and open competition. Genscript USA Inc., a...
- This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $10,982.04 contract is for the provision of customized protein services, gene synthesis, and other molecular biology products and services to support biomedical research and public health initiatives. The contract does not...
- This federal contract award was made by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $10,470.54 firm fixed price purchase order was awarded on November 1, 2019 with a completion date of October 29, 2020. Genscript provides a wide range of products and services to federal agencies in the areas of biomedical research...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, valued at $18,820.52, is for the production of customized DNA and monoclonal antibodies. The contract does not have a set-aside designation. Genscript USA Inc. is a for-profit organization that specializes in advanced...
- The U.S. government awarded Genscript USA Inc. a $6,582.14 firm fixed-price purchase order on September 12, 2016, for custom peptide synthesis and purification services. The contract, with an ultimate completion date of October 14, 2016, was funded by a civilian agency within the Pacific West Area and performed at the vendor's facility in Piscataway, New Jersey. No small business set-aside designation was applied to this award. Genscript USA Inc. is a biotechnology company specializing in...
- This firm fixed price purchase order was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company, to provide custom-produced biotinylated and non-biotinylated proteins. The $45,035.54 contract supports the mission of the Vaccine Research Center, which had previously used Genscript's proteins in downstream experiments. The contract has no set-aside designation. Genscript, based in Piscataway,...
The Office of Naval Research awarded a Purchase Order valued at $6,888.98 to Genscript USA Inc. on September 19, 2014, with completion targeted for December 31, 2014. This firm fixed-price contract was issued without a set-aside designation and involves protein-related products or services to be performed at the contractor's facility in Piscataway, New Jersey. Genscript USA Inc., a biotechnology company specializing in advanced molecular biology services, was selected to support the Navy's research requirements in this technical area. Genscript has established itself as a reliable vendor for federal life sciences research, providing specialized services including protein production, gene synthesis, and antibody development to multiple government agencies. The contractor's registration in the System for Award Management since July 2013 and its track record of delivering molecular biology support across the Department of Defense, National Institutes of Health, Centers for Disease Control and Prevention, and other federal agencies demonstrates its capability to execute research support contracts of varying scales. This particular award reflects the Office of Naval Research's utilization of commercial biotechnology expertise to support its scientific and research mission objectives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 9/18/14 |